Get started
CCC

CYXONE AB

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Seasonals

CYXO chart


Full chart

Key stats


Market capitalization
‪11.06 M‬ SEK
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.1360 SEK
Net income (FY)
‪−22.99 M‬ SEK
Revenue (FY)
0.00 SEK
Shares float
‪212.98 M‬
Beta (1Y)
−0.23

Employees


Employees (FY)
3
Change (1Y)
−4 −57.14%
Revenue / Employee (1Y)
0.00 SEK
Net income / Employee (1Y)
‪−756.34 K‬ SEK

About CYXONE AB


Sector
Health Technology
CEO
Kjell Göran Stenberg
Headquarters
Malmö
Website
cyxone.com
ISIN
SE0007815428
FIGI
BBG00CP2TWX3
Cyxone AB is a clinical stage biotechnology company, which engages in the development of immunomodulation drugs for the treatment of autoimmune diseases. Its product portfolio include T20K for multiple sclerosis in a preclinical program; and Rabeximod for rheumatoid arthritis and Covid-19. The company was founded by Bert Roland Kari Junno in July 13, 2015 and is headquartered in Malmo, Sweden.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

CYXO news



Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of CYXO is 0.0280 SEK — it has increased by 8.47% in the past 24 hours. Watch CYXONE AB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange CYXONE AB stocks are traded under the ticker CYXO.
CYXO stock has risen by 113.33% compared to the previous week, the month change is a −20.00% fall, over the last year CYXONE AB has showed a −81.05% decrease.
CYXO reached its all-time high on Oct 6, 2017 with the price of 12.3865 SEK, and its all-time low was 0.0100 SEK and was reached on Nov 11, 2024. View more price dynamics on CYXO chart.
See other stocks reaching their highest and lowest prices.
CYXO stock is 39.29% volatile and has beta coefficient of −0.23. Track CYXONE AB stock price on the chart and check out the list of the most volatile stocks — is CYXONE AB there?
Today CYXONE AB has the market capitalization of ‪11.06 M‬, it has increased by 84.37% over the last week.
Yes, you can track CYXONE AB financials in yearly and quarterly reports right on TradingView.
No, CYXO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 23, 2024, the company has 3.00 employees. See our rating of the largest employees — is CYXONE AB on this list?
Like other stocks, CYXO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CYXONE AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CYXONE AB technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CYXONE AB stock shows the sell signal. See more of CYXONE AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.